The Journal of Infectious Diseases · 2005 · 65 citations · 30 references
MedicineChild HealthPediatricsPediatric EpidemiologyPediatric ImmunologyPediatric Infectious DiseasesAntigen Detection AssaysImmunoassay AnalysisInfectious DiarrheaPediatric Diarrheal DisordersToxin-mediated DiseaseToxin-mediated PathogenesisAntibodiesCase-control Study DesignEnterotoxin-mediated DiseaseEscherichia ColiEscherichia Coli GastroenteritisHeat-labile EnterotoxinNested Case-control DesignSerologic Correlates Of Protection
BACKGROUND: We conducted a nested case-control study in 397 rural Egyptian children <36 months of age to assess the correlation between serum levels of antibodies against toxin and colonization factors (CFs) and the risk of homologous enterotoxigenic Escherichia coli (ETEC) diarrhea. METHODS: Active case detection was performed via semiweekly home visits, and blood was obtained at 3-month intervals. After each serosurvey, case subjects were selected from children experiencing a CF antigen (CFA)/I-, CFA/II-, CFA/IV-, or heat-labile enterotoxin (LT)-ETEC diarrheal episode during the subsequent 3 months. Up to 5 control subjects per case subject were selected from children who did not experience an ETEC diarrheal episode during the corresponding interval. Serum titers of immunoglobulin G antibodies against CFA/I, coli surface antigen (CS) 3, CS6, and LT were measured by enzyme-linked immunosorbant assay. RESULTS: The distribution of serum titers of LT, CS3, and CS6 antibodies did not differ between the case and control subjects. For children <18 months of age, serum titers of CFA/I antibody were inversely related to the risk of CFA/I-ETEC diarrhea; reciprocal serum titers of CFA/I antibody > or =76 were associated with a 77% reduction in the odds of CFA/I-ETEC diarrhea. CONCLUSION: Induction of reciprocal serum titers of antibodies against CFA/I within or above the 76-186 range should be further evaluated as a predictor for assessment of the ability of candidate vaccines to protect against CFA/I-ETEC diarrhea.
30
John D. Clemens, David A. Sack, Jeffrey R. Harris et al. · The Journal of Infectious Diseases · 1988 · 343 citations
Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine
Heikki Peltola, A. Siitonen, Matti Kataja et al. · The Lancet · 1991 · 275 citations